HEADER LIPID TRANSPORT 03-AUG-12 4B5C TITLE CRYSTAL STRUCTURE OF THE PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN FROM TITLE 2 BURKHOLDERIA PSEUDOMALLEI COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE OMPA FAMILY LIPOPROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 36-170; COMPND 5 SYNONYM: PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BURKHOLDERIA PSEUDOMALLEI; SOURCE 3 ORGANISM_TAXID: 28450; SOURCE 4 STRAIN: K96423; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET14B KEYWDS LIPID TRANSPORT, PAL-TOL COMPLEX, ACUTE BURKHOLDERIA PSEUODOMALLEI KEYWDS 2 ANTIGEN EXPDTA X-RAY DIFFRACTION AUTHOR L.J.GOURLAY,C.PERI,O.CONCHILLO-SOLE,M.FERRER-NAVARRO,A.GORI,R.LONGHI, AUTHOR 2 D.RINCHAI,G.LERTMEMONGKOLCHAI,P.LASSAUX,X.DAURA,G.COLOMBO, AUTHOR 3 M.BOLOGNESI REVDAT 4 20-DEC-23 4B5C 1 REMARK REVDAT 3 12-JUL-17 4B5C 1 REVDAT 2 13-NOV-13 4B5C 1 JRNL REVDAT 1 14-AUG-13 4B5C 0 JRNL AUTH L.J.GOURLAY,C.PERI,M.FERRER-NAVARRO,O.CONCHILLO-SOLE,A.GORI, JRNL AUTH 2 D.RINCHAI,R.J.THOMAS,O.L.CHAMPION,S.L.MICHELL, JRNL AUTH 3 C.KEWCHAROENWONG,A.NITHICHANON,P.LASSAUX,L.PERLETTI, JRNL AUTH 4 R.LONGHI,G.LERTMEMONGKOLCHAI,R.W.TITBALL,X.DAURA,G.COLOMBO, JRNL AUTH 5 M.BOLOGNESI JRNL TITL EXPLOITING THE BURKHOLDERIA PSEUDOMALLEI ACUTE PHASE ANTIGEN JRNL TITL 2 BPSL2765 FOR STRUCTURE-BASED EPITOPE DISCOVERY/DESIGN IN JRNL TITL 3 STRUCTURAL VACCINOLOGY. JRNL REF CHEM.BIOOL. V. 20 1147 2013 JRNL REFN ISSN 1074-5521 JRNL PMID 23993463 JRNL DOI 10.1016/J.CHEMBIOL.2013.07.010 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 16673 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.4800 - 4.1778 0.97 2694 136 0.1851 0.1984 REMARK 3 2 4.1778 - 3.3167 0.97 2635 144 0.1900 0.2325 REMARK 3 3 3.3167 - 2.8976 0.97 2628 146 0.2176 0.2658 REMARK 3 4 2.8976 - 2.6327 0.97 2637 131 0.2309 0.2820 REMARK 3 5 2.6327 - 2.4441 0.97 2633 122 0.2418 0.3379 REMARK 3 6 2.4441 - 2.3000 0.96 2605 162 0.2470 0.3072 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 44.32 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.660 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.89800 REMARK 3 B22 (A**2) : -8.76670 REMARK 3 B33 (A**2) : -9.13130 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.73490 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2920 REMARK 3 ANGLE : 0.513 3953 REMARK 3 CHIRALITY : 0.036 417 REMARK 3 PLANARITY : 0.001 541 REMARK 3 DIHEDRAL : 12.079 1095 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4B5C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1290053478. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16804 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 1OAP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG10K, 0.1M SODIUM ACETATE PH REMARK 280 5.3, 30% GLYCEROL FOR CRYOPROTECTION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.97000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.47500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.97000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.47500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 33 REMARK 465 SER A 34 REMARK 465 HIS A 35 REMARK 465 ALA A 36 REMARK 465 VAL A 37 REMARK 465 SER A 38 REMARK 465 THR A 39 REMARK 465 GLN A 40 REMARK 465 PRO A 41 REMARK 465 ASN A 42 REMARK 465 PRO A 43 REMARK 465 GLU A 44 REMARK 465 ASN A 45 REMARK 465 VAL A 46 REMARK 465 ALA A 47 REMARK 465 GLN A 48 REMARK 465 VAL A 49 REMARK 465 THR A 50 REMARK 465 VAL A 51 REMARK 465 GLY B 33 REMARK 465 SER B 34 REMARK 465 HIS B 35 REMARK 465 ALA B 36 REMARK 465 VAL B 37 REMARK 465 SER B 38 REMARK 465 THR B 39 REMARK 465 GLN B 40 REMARK 465 PRO B 41 REMARK 465 ASN B 42 REMARK 465 PRO B 43 REMARK 465 GLU B 44 REMARK 465 ASN B 45 REMARK 465 VAL B 46 REMARK 465 ALA B 47 REMARK 465 GLN B 48 REMARK 465 VAL B 49 REMARK 465 GLN B 170 REMARK 465 GLY C 33 REMARK 465 SER C 34 REMARK 465 HIS C 35 REMARK 465 ALA C 36 REMARK 465 VAL C 37 REMARK 465 SER C 38 REMARK 465 THR C 39 REMARK 465 GLN C 40 REMARK 465 PRO C 41 REMARK 465 ASN C 42 REMARK 465 PRO C 43 REMARK 465 GLU C 44 REMARK 465 ASN C 45 REMARK 465 VAL C 46 REMARK 465 ALA C 47 REMARK 465 GLN C 48 REMARK 465 VAL C 49 REMARK 465 THR C 50 REMARK 465 VAL C 51 REMARK 465 GLN C 170 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS C 147 O REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 95 OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 71 OH TYR B 112 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 153 52.44 -108.62 REMARK 500 ARG B 64 19.25 -141.97 REMARK 500 LYS B 147 68.48 -113.73 REMARK 500 HIS B 153 49.77 -100.61 REMARK 500 ARG C 64 39.82 -140.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1171 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1170 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C 1170 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4B54 RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE INACTIVE MUTANT G153R OF LPTC FROM E. COLI REMARK 999 REMARK 999 SEQUENCE REMARK 999 SIGNAL PEPTIDE WAS REMOVED. THE FIRST TWO RESIDUES (GS) REMARK 999 CORRESPOND TO THE VECTOR AFTER HIS-TAG THROMBIN CLEAVAGE DBREF 4B5C A 36 170 UNP Q63RA7 Q63RA7_BURPS 36 170 DBREF 4B5C B 36 170 UNP Q63RA7 Q63RA7_BURPS 36 170 DBREF 4B5C C 36 170 UNP Q63RA7 Q63RA7_BURPS 36 170 SEQADV 4B5C GLY A 33 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C SER A 34 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C HIS A 35 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C GLY B 33 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C SER B 34 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C HIS B 35 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C GLY C 33 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C SER C 34 UNP Q63RA7 EXPRESSION TAG SEQADV 4B5C HIS C 35 UNP Q63RA7 EXPRESSION TAG SEQRES 1 A 138 GLY SER HIS ALA VAL SER THR GLN PRO ASN PRO GLU ASN SEQRES 2 A 138 VAL ALA GLN VAL THR VAL ASP PRO LEU ASN ASP PRO ASN SEQRES 3 A 138 SER PRO LEU ALA LYS ARG SER VAL TYR PHE ASP PHE ASP SEQRES 4 A 138 SER TYR SER VAL GLN ASP GLN TYR GLN ALA LEU LEU GLN SEQRES 5 A 138 GLN HIS ALA GLN TYR LEU LYS SER HIS PRO GLN ARG HIS SEQRES 6 A 138 ILE LEU ILE GLN GLY ASN THR ASP GLU ARG GLY THR SER SEQRES 7 A 138 GLU TYR ASN LEU ALA LEU GLY GLN LYS ARG ALA GLU ALA SEQRES 8 A 138 VAL ARG ARG ALA LEU SER LEU LEU GLY VAL GLY ASP ALA SEQRES 9 A 138 GLN MET GLU ALA VAL SER LEU GLY LYS GLU LYS PRO VAL SEQRES 10 A 138 ALA LEU GLY HIS ASP GLU ALA SER TRP ALA GLN ASN ARG SEQRES 11 A 138 ARG ALA ASP LEU VAL TYR GLN GLN SEQRES 1 B 138 GLY SER HIS ALA VAL SER THR GLN PRO ASN PRO GLU ASN SEQRES 2 B 138 VAL ALA GLN VAL THR VAL ASP PRO LEU ASN ASP PRO ASN SEQRES 3 B 138 SER PRO LEU ALA LYS ARG SER VAL TYR PHE ASP PHE ASP SEQRES 4 B 138 SER TYR SER VAL GLN ASP GLN TYR GLN ALA LEU LEU GLN SEQRES 5 B 138 GLN HIS ALA GLN TYR LEU LYS SER HIS PRO GLN ARG HIS SEQRES 6 B 138 ILE LEU ILE GLN GLY ASN THR ASP GLU ARG GLY THR SER SEQRES 7 B 138 GLU TYR ASN LEU ALA LEU GLY GLN LYS ARG ALA GLU ALA SEQRES 8 B 138 VAL ARG ARG ALA LEU SER LEU LEU GLY VAL GLY ASP ALA SEQRES 9 B 138 GLN MET GLU ALA VAL SER LEU GLY LYS GLU LYS PRO VAL SEQRES 10 B 138 ALA LEU GLY HIS ASP GLU ALA SER TRP ALA GLN ASN ARG SEQRES 11 B 138 ARG ALA ASP LEU VAL TYR GLN GLN SEQRES 1 C 138 GLY SER HIS ALA VAL SER THR GLN PRO ASN PRO GLU ASN SEQRES 2 C 138 VAL ALA GLN VAL THR VAL ASP PRO LEU ASN ASP PRO ASN SEQRES 3 C 138 SER PRO LEU ALA LYS ARG SER VAL TYR PHE ASP PHE ASP SEQRES 4 C 138 SER TYR SER VAL GLN ASP GLN TYR GLN ALA LEU LEU GLN SEQRES 5 C 138 GLN HIS ALA GLN TYR LEU LYS SER HIS PRO GLN ARG HIS SEQRES 6 C 138 ILE LEU ILE GLN GLY ASN THR ASP GLU ARG GLY THR SER SEQRES 7 C 138 GLU TYR ASN LEU ALA LEU GLY GLN LYS ARG ALA GLU ALA SEQRES 8 C 138 VAL ARG ARG ALA LEU SER LEU LEU GLY VAL GLY ASP ALA SEQRES 9 C 138 GLN MET GLU ALA VAL SER LEU GLY LYS GLU LYS PRO VAL SEQRES 10 C 138 ALA LEU GLY HIS ASP GLU ALA SER TRP ALA GLN ASN ARG SEQRES 11 C 138 ARG ALA ASP LEU VAL TYR GLN GLN HET ACT A1171 14 HET ACT B1170 14 HET ACT C1170 14 HETNAM ACT ACETATE ION FORMUL 4 ACT 3(C2 H3 O2 1-) FORMUL 7 HOH *60(H2 O) HELIX 1 1 ASP A 52 ASP A 56 5 5 HELIX 2 2 SER A 59 LYS A 63 5 5 HELIX 3 3 GLN A 76 GLN A 78 5 3 HELIX 4 4 TYR A 79 HIS A 93 1 15 HELIX 5 5 THR A 109 LEU A 131 1 23 HELIX 6 6 ASP A 154 GLN A 160 1 7 HELIX 7 7 ASP B 52 ASP B 56 5 5 HELIX 8 8 SER B 59 LYS B 63 5 5 HELIX 9 9 GLN B 76 GLN B 78 5 3 HELIX 10 10 TYR B 79 SER B 92 1 14 HELIX 11 11 THR B 109 LEU B 131 1 23 HELIX 12 12 GLY B 134 ALA B 136 5 3 HELIX 13 13 ASP B 154 ARG B 162 1 9 HELIX 14 14 SER C 59 LYS C 63 5 5 HELIX 15 15 GLN C 76 GLN C 78 5 3 HELIX 16 16 TYR C 79 HIS C 93 1 15 HELIX 17 17 THR C 109 LEU C 131 1 23 HELIX 18 18 GLY C 134 ALA C 136 5 3 HELIX 19 19 ASP C 154 ARG C 162 1 9 SHEET 1 AA 4 SER A 65 TYR A 67 0 SHEET 2 AA 4 ARG A 163 TYR A 168 -1 O ALA A 164 N VAL A 66 SHEET 3 AA 4 ILE A 98 ASN A 103 -1 O LEU A 99 N VAL A 167 SHEET 4 AA 4 MET A 138 GLY A 144 1 O GLU A 139 N ILE A 100 SHEET 1 BA 4 SER B 65 TYR B 67 0 SHEET 2 BA 4 ARG B 163 TYR B 168 -1 O ALA B 164 N VAL B 66 SHEET 3 BA 4 ILE B 98 GLY B 102 -1 O LEU B 99 N VAL B 167 SHEET 4 BA 4 MET B 138 SER B 142 1 O GLU B 139 N ILE B 100 SHEET 1 CA 4 SER C 65 TYR C 67 0 SHEET 2 CA 4 ARG C 163 GLN C 169 -1 O ALA C 164 N VAL C 66 SHEET 3 CA 4 HIS C 97 GLY C 102 -1 O HIS C 97 N GLN C 169 SHEET 4 CA 4 MET C 138 SER C 142 1 O GLU C 139 N ILE C 100 SITE 1 AC1 8 ASP A 71 THR A 104 ASP A 105 ARG A 107 SITE 2 AC1 8 ASN A 113 LEU A 116 ARG A 120 ARG A 162 SITE 1 AC2 7 PHE B 70 ASP B 105 ARG B 107 ASN B 113 SITE 2 AC2 7 LEU B 116 ARG B 120 ARG B 162 SITE 1 AC3 9 PHE C 70 ASP C 71 THR C 104 ASP C 105 SITE 2 AC3 9 ARG C 107 ASN C 113 LEU C 116 ARG C 120 SITE 3 AC3 9 ARG C 162 CRYST1 101.940 74.950 72.920 90.00 135.28 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009810 0.000000 0.009906 0.00000 SCALE2 0.000000 0.013342 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019490 0.00000